A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to <18 years of age, with chronic kidney disease and proteinuria

  • Johnstone, Lilian (Primary Chief Investigator (PCI))

Project: Research

Project Details

Effective start/end date21/03/2220/03/27


  • multicentre trial
  • kidney disease
  • treatment safety
  • treatment efficacy
  • randomised controlled trial (RCT)